{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:02:19Z","timestamp":1771012939673,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1097\/chi.0b013e318193060e","type":"journal-article","created":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T03:19:56Z","timestamp":1231989596000},"page":"176-185","source":"Crossref","is-referenced-by-count":53,"title":["Safety and Tolerability of Atomoxetine Over 3 to 4 Years in Children and Adolescents With ADHD"],"prefix":"10.1016","volume":"48","author":[{"given":"Craig","family":"Donnelly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Bangs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Trzepacz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan G.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/CHI.0b013e318193060e_bib1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1097\/CHI.0b013e318193060e_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/CHI.0b013e3180686d48","article-title":"3-Year follow-up of the NIMH MTA study","volume":"46","author":"Jensen","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318193060e_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00004714-199508000-00006","article-title":"Pharmacotherapy of adult attention deficit\/hyperactivity disorder: a review","volume":"15","author":"Wilens","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"10.1097\/CHI.0b013e318193060e_bib4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1542\/peds.108.4.1033","article-title":"Clinical practice guideline: treatment of the school-aged child with attention-deficit\/hyperactivity disorder","volume":"108","year":"2001","journal-title":"Pediatrics"},{"key":"10.1097\/CHI.0b013e318193060e_bib5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","article-title":"A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD","volume":"56","author":"The MTA Cooperative Group","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/CHI.0b013e318193060e_bib6","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/01.chi.0000125089.35109.81","article-title":"Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study","volume":"43","author":"Michelson","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318193060e_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.114.1.e1","article-title":"Once-daily atomoxetine treatment for children with attention-deficit\/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial","volume":"114","author":"Kelsey","year":"2004","journal-title":"Pediatrics"},{"key":"10.1097\/CHI.0b013e318193060e_bib8","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1176\/appi.ajp.159.11.1896","article-title":"Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study","volume":"159","author":"Michelson","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1097\/CHI.0b013e318193060e_bib9","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1542\/peds.108.5.e83","article-title":"Atomoxetine in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder: a randomized, placebo-controlled, dose-response study","volume":"108","author":"Michelson","year":"2001","journal-title":"Pediatrics"},{"key":"10.1097\/CHI.0b013e318193060e_bib10","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.4088\/JCP.v63n1209","article-title":"Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit\/hyperactivity disorder","volume":"63","author":"Spencer","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/CHI.0b013e318193060e_bib11","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00004583-200207000-00008","article-title":"Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial","volume":"41","author":"Kratochvil","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318193060e_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpeds.2006.01.052","article-title":"Long-term atomoxetine treatment in adolescents with attention-deficit\/hyperactivity disorder","volume":"149","author":"Wilens","year":"2006","journal-title":"J Pediatr"},{"key":"10.1097\/CHI.0b013e318193060e_bib13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.chi.0000222788.34229.68","article-title":"Effects of long-term atomoxetine treatment for young children with attention-deficit\/hyperactivity disorder","volume":"45","author":"Kratochvil","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318193060e_bib14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/cap.2006.0100","article-title":"Effects of atomoxetine on growth in children with attention-deficit\/hyperactivity disorder following up to five years of treatment","volume":"17","author":"Spencer","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"suppl 12","key":"10.1097\/CHI.0b013e318193060e_bib15","first-page":"50","article-title":"Safety profile of atomoxetine in the treatment of children and adolescents with ADHD","volume":"63","author":"Wernicke","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/CHI.0b013e318193060e_bib16","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/01.chi.0000169012.81536.38","article-title":"Atomoxetine alone or combined with fluoxetine for treating ADHD comorbid with depressive or anxiety symptoms","volume":"44","author":"Kratochvil","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318193060e_bib17","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1212\/01.wnl.0000188869.58300.a7","article-title":"Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders","volume":"65","author":"Allen","year":"2005","journal-title":"Neurology"},{"key":"10.1097\/CHI.0b013e318193060e_bib18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/01.chi.0000163280.47221.c9","article-title":"A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD","volume":"44","author":"Weiss","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318193060e_bib19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1176\/appi.ajp.2007.05091676","article-title":"Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response","volume":"165","author":"Newcorn","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1097\/CHI.0b013e318193060e_bib20","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/sleep\/29.12.1573","article-title":"Effects of atomoxetine and methylphenidate on sleep in children with ADHD","volume":"29","author":"Sangal","year":"2006","journal-title":"Sleep"},{"key":"10.1097\/CHI.0b013e318193060e_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/10445460152595577","article-title":"An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder","volume":"11","author":"Spencer","year":"2001","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1097\/CHI.0b013e318193060e_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euroneuro.2007.06.002","article-title":"CYP2D6 metabolizer status and atomoxetine dosing in children and adolescents with ADHD","volume":"18","author":"Trzepacz","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1097\/CHI.0b013e318193060e_bib23","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision","year":"2000"},{"key":"10.1097\/CHI.0b013e318193060e_bib24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/01.chi.0000246056.83791.b6","article-title":"CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD","volume":"46","author":"Michelson","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318193060e_bib25","series-title":"The Assessment of the Potential for QT Interval Prolongation by Non-Cardiovascular Medicinal Products","author":"Committee for Proprietary Medicinal Products","year":"1997"},{"key":"10.1097\/CHI.0b013e318193060e_bib26","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1542\/peds.2004-0624","article-title":"Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit\/hyperactivity disorder","volume":"116","author":"Spencer","year":"2005","journal-title":"Pediatrics"},{"key":"10.1097\/CHI.0b013e318193060e_bib27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/chi.0b013e3180686d7e","article-title":"Effects of stimulant medication on growth rates across 3 years in the MTA follow-up","volume":"46","author":"Swanson","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318193060e_bib28","series-title":"Current Diagnosis and Treatment in Pediatrics","year":"2007"},{"key":"10.1097\/CHI.0b013e318193060e_bib29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2165\/00002018-200326100-00006","article-title":"Cardiovascular effects of atomoxetine in children, adolescents, and adults","volume":"26","author":"Wernicke","year":"2003","journal-title":"Drug Saf"},{"key":"10.1097\/CHI.0b013e318193060e_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1753-2000-1-11","article-title":"Baseline values from the electrocardiograms of children and adolescents with ADHD","volume":"1","author":"Prasad","year":"2007","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"10.1097\/CHI.0b013e318193060e_bib31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1097\/CHI.0b013e318193060e_bib32","series-title":"Atomoxetine hydrochloride. US Full Prescribing Information","first-page":"1","year":"2007"},{"issue":"2","key":"10.1097\/CHI.0b013e318193060e_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/chi.0b013e31815d88b2","article-title":"Meta-analysis of suicide-related behavior events in patients treated with atomoxetine","volume":"47","author":"Bangs","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/CHI.0b013e318193060e_bib34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00008571-199812000-00010","article-title":"CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles","volume":"8","author":"Leathart","year":"1998","journal-title":"Pharmacogenetics"},{"key":"10.1097\/CHI.0b013e318193060e_bib35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0009-9236(99)70077-9","article-title":"Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population","volume":"65","author":"Tateishi","year":"1999","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709600113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709600113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T04:54:59Z","timestamp":1558068899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856709600113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0890856709600113"],"URL":"https:\/\/doi.org\/10.1097\/chi.0b013e318193060e","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}